3((2-Chloro-10H-phenothiazin-10-yl)methyl)aniline

ID: ALA5198457

Chembl Id: CHEMBL5198457

PubChem CID: 168285674

Max Phase: Preclinical

Molecular Formula: C19H15ClN2S

Molecular Weight: 338.86

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1cccc(CN2c3ccccc3Sc3ccc(Cl)cc32)c1

Standard InChI:  InChI=1S/C19H15ClN2S/c20-14-8-9-19-17(11-14)22(12-13-4-3-5-15(21)10-13)16-6-1-2-7-18(16)23-19/h1-11H,12,21H2

Standard InChI Key:  RFSGPPYSYWTBTL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5198457

    ---

Associated Targets(Human)

PSMB2 Tclin 20S proteasome (530 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 338.86Molecular Weight (Monoisotopic): 338.0644AlogP: 5.73#Rotatable Bonds: 2
Polar Surface Area: 29.26Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.99CX LogP: 5.35CX LogD: 5.35
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.61Np Likeness Score: -1.50

References

1. Staerz SD, Jones CL, Tepe JJ..  (2022)  Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies.,  65  (9.0): [PMID:35476454] [10.1021/acs.jmedchem.1c02158]

Source